View in EDS

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.

Saved in:
Bibliographic Details
Title: Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.
Authors: Corona M; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain., García-Vicente R; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain., Saez-Marin AJ; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Ancos-Pintado R; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain., Rodríguez-Garcia A; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain., Arroyo A; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain., Blanco A; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Chari A; Hematology Department, University of California San Francisco, San Francisco, California, USA., Martin T; Hematology Department, University of California San Francisco, San Francisco, California, USA., Wolf J; Hematology Department, University of California San Francisco, San Francisco, California, USA., Rey-Bua B; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain., Mateos MV; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain., Kortüm KM; Hematology Department, University Hospital Würzburg, Würzburg, Germany., Riedhammer C; Hematology Department, University Hospital Würzburg, Würzburg, Germany., Tamariz-Amador LE; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Valencia E; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Rodríguez-Otero P; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., San Miguel J; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain., Ibarra G; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Oriol A; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain., Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., López-Muñoz N; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Alonso R; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Calbacho M; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Sanchez-Pina JM; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Linares M; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Medicine, Medicine School, Universidad Complutense de Madrid, Madrid, Spain.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Mar 06; Vol. 14 (3). Date of Electronic Publication: 2026 Mar 06.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41791791
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Corona+M%22">Corona M</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Vicente+R%22">García-Vicente R</searchLink>; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Saez-Marin+AJ%22">Saez-Marin AJ</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ancos-Pintado+R%22">Ancos-Pintado R</searchLink>; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Garcia+A%22">Rodríguez-Garcia A</searchLink>; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arroyo+A%22">Arroyo A</searchLink>; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco+A%22">Blanco A</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Chari+A%22">Chari A</searchLink>; Hematology Department, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Martin+T%22">Martin T</searchLink>; Hematology Department, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wolf+J%22">Wolf J</searchLink>; Hematology Department, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Rey-Bua+B%22">Rey-Bua B</searchLink>; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Kortüm+KM%22">Kortüm KM</searchLink>; Hematology Department, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Riedhammer+C%22">Riedhammer C</searchLink>; Hematology Department, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Tamariz-Amador+LE%22">Tamariz-Amador LE</searchLink>; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Valencia+E%22">Valencia E</searchLink>; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Otero+P%22">Rodríguez-Otero P</searchLink>; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22San+Miguel+J%22">San Miguel J</searchLink>; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ibarra+G%22">Ibarra G</searchLink>; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Oriol+A%22">Oriol A</searchLink>; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Cedena+MT%22">Cedena MT</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-Muñoz+N%22">López-Muñoz N</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso+R%22">Alonso R</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Calbacho+M%22">Calbacho M</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Pina+JM%22">Sanchez-Pina JM</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Linares+M%22">Linares M</searchLink>; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-López+J%22">Martínez-López J</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Medicine, Medicine School, Universidad Complutense de Madrid, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2026 Mar 06; Vol. 14 (3). <i>Date of Electronic Publication: </i>2026 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41791791
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-014224
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Corona M
      – PersonEntity:
          Name:
            NameFull: García-Vicente R
      – PersonEntity:
          Name:
            NameFull: Saez-Marin AJ
      – PersonEntity:
          Name:
            NameFull: Ancos-Pintado R
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Garcia A
      – PersonEntity:
          Name:
            NameFull: Arroyo A
      – PersonEntity:
          Name:
            NameFull: Blanco A
      – PersonEntity:
          Name:
            NameFull: Chari A
      – PersonEntity:
          Name:
            NameFull: Martin T
      – PersonEntity:
          Name:
            NameFull: Wolf J
      – PersonEntity:
          Name:
            NameFull: Rey-Bua B
      – PersonEntity:
          Name:
            NameFull: Mateos MV
      – PersonEntity:
          Name:
            NameFull: Kortüm KM
      – PersonEntity:
          Name:
            NameFull: Riedhammer C
      – PersonEntity:
          Name:
            NameFull: Tamariz-Amador LE
      – PersonEntity:
          Name:
            NameFull: Valencia E
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Otero P
      – PersonEntity:
          Name:
            NameFull: San Miguel J
      – PersonEntity:
          Name:
            NameFull: Ibarra G
      – PersonEntity:
          Name:
            NameFull: Oriol A
      – PersonEntity:
          Name:
            NameFull: Cedena MT
      – PersonEntity:
          Name:
            NameFull: López-Muñoz N
      – PersonEntity:
          Name:
            NameFull: Alonso R
      – PersonEntity:
          Name:
            NameFull: Calbacho M
      – PersonEntity:
          Name:
            NameFull: Sanchez-Pina JM
      – PersonEntity:
          Name:
            NameFull: Linares M
      – PersonEntity:
          Name:
            NameFull: Martínez-López J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 03
              Text: 2026 Mar 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1